From Clinical Thyroidology® for the Public: Overall, ~ 10-15% thyroid nodule biopsies are indeterminate, which means that the cells are not either clearly abnormal or clearly normal. Molecular marker testing may be helpful in evaluating indeterminate nodules but us expensive. In this study, the authors analyze a unique clinical group of patients in whom repeat biopsy was obtained prior to molecular testing in almost all cases to evaluate the implications of performing a repeat biopsy before molecular diagnostic testing indeterminate nodules. Read More…
We welcome your feedback and suggestions. Let us know what you want to see in this publication.
Feedback & Suggestions
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.